Pharmaceutical Grade 4-Nitro-2,3-Lutidine-N-Oxide Coa Specs
Securing reliable supply chains for critical API intermediates often presents procurement teams with challenges regarding batch-to-batch variability and Certificate of Analysis verification delays.
Technical Specifications and Analytical Methods
Our pharmaceutical grade 4-Nitro-2,3-lutidine-N-oxide (CAS: 37699-43-7) is synthesized to meet rigorous industrial purity standards required for Lansoprazole production. Also known as 2,3-Dimethyl-4-nitropyridine N-Oxide, this pyridine N-oxide intermediate undergoes strict HPLC testing.
| Parameter | Specification | Method |
|---|---|---|
| CAS Number | 37699-43-7 | - |
| Molecular Formula | C7H8N2O3 | - |
| Purity (HPLC) | >98.0% | HPLC |
| Appearance | Yellow to Orange Solid | Visual |
Formulation Compatibility and Drop-in Replacement Advantages
Engineered as a seamless Lutidine N-oxide derivative, our product ensures stability in downstream reactions. For detailed insights into optimization, review our 2,3-Dimethyl-4-Nitropyridine N-Oxide Manufacturing Process Synthesis Route.
- Consistent particle size distribution for improved solubility
- Low heavy metal content suitable for sensitive catalytic steps
- Validated stability profiles under standard storage conditions
- Compatible with existing Lansoprazole synthesis workflows
Strict Quality Assurance Workflow and COA Verification
At NINGBO INNO PHARMCHEM CO.,LTD., every batch is accompanied by a comprehensive COA. Procurement officers can verify bulk price stability and quality metrics via our 4-Nitro-2,3-Lutidine-N-Oxide Bulk Price 2026 Global Manufacturer report.
Partner with a trusted global manufacturer for your API intermediate needs. We ensure consistent supply and documentation compliance at NINGBO INNO PHARMCHEM CO.,LTD.
For custom synthesis requirements or to validate our drop-in replacement data, consult with our process engineers directly.
